These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7486901)

  • 21. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Marriott C; Ranasinha C; Hodson ME
    Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathophysiology of chronic, bronchial hypersecretion (author's transl)].
    Puchelle E; Girard F; Polu JM; Aug F; Sadoul P
    Pathol Biol (Paris); 1978 Oct; 26(7):441-51. PubMed ID: 372900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C
    Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis.
    Tamaoki J; Chiyotani A; Kobayashi K; Sakai N; Kanemura T; Takizawa T
    Am Rev Respir Dis; 1992 Mar; 145(3):548-52. PubMed ID: 1546834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indomethacin inhalation therapy].
    Tamaoki J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1426-31. PubMed ID: 1705297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rheological properties of sputum.
    Davis SS; Dippy JE
    Biorheology; 1969 Apr; 6(1):11-21. PubMed ID: 5806400
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
    Banerjee D; Honeybourne D; Khair OA
    Treat Respir Med; 2004; 3(1):59-65. PubMed ID: 15174894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
    Vagliasindi M
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a thromboxane A(2) antagonist on sputum production and its physicochemical properties in patients with mild to moderate asthma.
    Tamaoki J; Kondo M; Nakata J; Nagano Y; Isono K; Nagai A
    Chest; 2000 Jul; 118(1):73-9. PubMed ID: 10893362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinability of bronchial mucus. Relationship with viscoelasticity and mucous transport properties.
    Puchelle E; Zahm JM; Duvivier C
    Biorheology; 1983; 20(2):239-49. PubMed ID: 6871438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
    Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
    Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucociliary transport in vivo and in vitro. Relations to sputum properties in chronic bronchitis.
    Puchelle E; Zahm JM; Girard F; Bertrand A; Polu JM; Aug F; Sadoul P
    Eur J Respir Dis; 1980 Oct; 61(5):254-64. PubMed ID: 7202598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Criteria for evaluating mucus functions and their disorders in chronic bronchitis.
    Sadoul P; Puchelle E; Girard F
    Ciba Found Symp; 1978; (54):277-95. PubMed ID: 248016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.
    Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C
    Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
    Shibuya Y; Wills PJ; Cole PJ
    Respiration; 2001; 68(6):615-9. PubMed ID: 11786718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients.
    Nielsen H; Hvidt S; Sheils CA; Janmey PA
    Biophys Chem; 2004 Dec; 112(2-3):193-200. PubMed ID: 15572248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rheological properties of bronchial secretions in chronic bronchitis patients].
    Puchelle E; Pham QT; Caraux G; Zahm JM
    Bull Physiopathol Respir (Nancy); 1973; 9(1):143-59. PubMed ID: 4712228
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro restructuring effect of human airway immunoglobulins A and lysozyme on airway secretions.
    Puchelle E; Jacqot J; Zahm JM
    Eur J Respir Dis Suppl; 1987; 153():117-22. PubMed ID: 3480810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.